S. Giard

2.0k total citations
66 papers, 1.2k citations indexed

About

S. Giard is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, S. Giard has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cancer Research, 32 papers in Pathology and Forensic Medicine and 27 papers in Oncology. Recurrent topics in S. Giard's work include Breast Cancer Treatment Studies (54 papers), Breast Lesions and Carcinomas (32 papers) and Breast Implant and Reconstruction (16 papers). S. Giard is often cited by papers focused on Breast Cancer Treatment Studies (54 papers), Breast Lesions and Carcinomas (32 papers) and Breast Implant and Reconstruction (16 papers). S. Giard collaborates with scholars based in France, United States and Switzerland. S. Giard's co-authors include H. Mignotte, Jean‐Marc Classe, Pierre‐François Dupré, C. Tunon de Lara, B. Cutuli, F. Dravet, B. De Lafontan, L. Campion, Gilles Houvenaeghel and Jean Lévêque and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

S. Giard

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Giard France 20 982 663 469 428 145 66 1.2k
Stella Hetelekidis United States 12 782 0.8× 592 0.9× 260 0.6× 411 1.0× 107 0.7× 23 1.2k
J.P. Travagli France 15 493 0.5× 334 0.5× 298 0.6× 325 0.8× 71 0.5× 22 961
Pandora Ashley United States 3 751 0.8× 395 0.6× 583 1.2× 198 0.5× 106 0.7× 3 1.1k
Kristine E. Kokeny United States 14 409 0.4× 188 0.3× 304 0.6× 260 0.6× 102 0.7× 40 812
Ashu Gandhi United Kingdom 19 488 0.5× 288 0.4× 360 0.8× 430 1.0× 89 0.6× 50 1.1k
Shu Wan Kau United States 12 633 0.6× 418 0.6× 453 1.0× 155 0.4× 73 0.5× 14 843
Hanne Melgaard Nielsen Denmark 18 1.5k 1.5× 753 1.1× 687 1.5× 558 1.3× 312 2.2× 32 1.9k
Werner Audretsch Germany 15 582 0.6× 255 0.4× 186 0.4× 457 1.1× 134 0.9× 34 895
F. Laki France 14 475 0.5× 278 0.4× 216 0.5× 182 0.4× 90 0.6× 40 658
Jai Min Ryu South Korea 18 584 0.6× 257 0.4× 365 0.8× 328 0.8× 97 0.7× 114 1.0k

Countries citing papers authored by S. Giard

Since Specialization
Citations

This map shows the geographic impact of S. Giard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Giard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Giard more than expected).

Fields of papers citing papers by S. Giard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Giard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Giard. The network helps show where S. Giard may publish in the future.

Co-authorship network of co-authors of S. Giard

This figure shows the co-authorship network connecting the top 25 collaborators of S. Giard. A scholar is included among the top collaborators of S. Giard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Giard. S. Giard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Houvenaeghel, Gilles, Éric Lambaudie, Jean‐Marc Classe, et al.. (2019). Lymph node positivity in different early breast carcinoma phenotypes: a predictive model. BMC Cancer. 19(1). 45–45. 18 indexed citations
2.
Tresch, Emmanuelle, et al.. (2017). Nipple sparing mastectomy for breast cancer is associated with high patient satisfaction and safe oncological outcomes. Journal of Gynecology Obstetrics and Human Reproduction. 46(8). 637–642. 27 indexed citations
3.
Houvenaeghel, Gilles, Mellie Heinemann, Fabien Reyal, et al.. (2016). Breast cancer in young women: Pathologic features and molecular phenotype. The Breast. 29. 109–116. 31 indexed citations
4.
Houvenaeghel, Gilles, Jean‐Marie Boher, Fabien Reyal, et al.. (2016). Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. European Journal of Cancer. 67. 106–118. 20 indexed citations
5.
Houvenaeghel, Gilles, Renaud Sabatier, Fabien Reyal, et al.. (2016). Axillary lymph node micrometastases decrease triple-negative early breast cancer survival. British Journal of Cancer. 115(9). 1024–1031. 25 indexed citations
6.
Cheurfa, Nadir & S. Giard. (2014). Cancer du sein infra-clinique sur biopsie percutanée sans lésion maligne sur la pièce opératoire : comment gérer ?. Gynécologie Obstétrique & Fertilité. 43(1). 18–24. 1 indexed citations
7.
Houvenaeghel, Gilles, Jean Marc Classe, S. Giard, et al.. (2014). Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts. BMC Cancer. 14(1). 868–868. 8 indexed citations
8.
Besnard, S., et al.. (2012). Radiothérapie du cancer du sein infiltrant : recommandations nationales françaises. Cancer/Radiothérapie. 16(5-6). 503–513. 7 indexed citations
9.
Avril, A., G. Le Bouëdec, G. Lorimier, et al.. (2011). Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. European Journal of Surgical Oncology. 37(7). 563–570. 16 indexed citations
10.
Baranzelli, M.C., Frédérique Penault‐Llorca, Florence Mishellany, et al.. (2010). Utilisation d’une méthode PCR en temps réel pour l’étude des ganglions sentinelles dans les carcinomes mammaires : expérience des centres anticancéreux de Lille et de Clermont-Ferrand. Bulletin du Cancer. 97(3). 349–355. 3 indexed citations
11.
Lemanski, C., B. De Lafontan, C. Charra-Brunaud, et al.. (2010). Ductal carcinoma in situ of the breast in younger women: A subgroup of patients at high risk. European Journal of Surgical Oncology. 36(12). 1165–1171. 16 indexed citations
12.
13.
Houvenæghel, Gilles, Claude Nos, S. Giard, et al.. (2008). A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. European Journal of Surgical Oncology. 35(7). 690–695. 62 indexed citations
14.
Lara, C. Tunon de, S. Giard, Max Buttarelli, et al.. (2008). Sentinel Node Procedure is Warranted in Ductal Carcinoma In Situ with High Risk of Occult Invasive Carcinoma and Microinvasive Carcinoma Treated by Mastectomy. The Breast Journal. 14(2). 135–140. 33 indexed citations
15.
Giard, S., Marie‐Pierre Chauvet, & Mehrdad Jafari. (2006). [Implementation of sentinel node biopsy for breast cancer in the North of France].. PubMed. 93(7). 737–40.
16.
Giard, S., et al.. (2006). Pour ou contre la surveillance intensive après traitement des cancers du sein. Gynécologie Obstétrique & Fertilité. 34(3). 267–267. 1 indexed citations
17.
Cutuli, B., Renaud Fay, B. De Lafontan, et al.. (2004). Carcinome canalaire in situ du sein. La Presse Médicale. 33(2). 83–89. 7 indexed citations
18.
Cutuli, B., B. De Lafontan, H. Mignotte, et al.. (2002). Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience. International Journal of Radiation Oncology*Biology*Physics. 53(4). 868–879. 96 indexed citations
19.
Cutuli, B., B. De Lafontan, H. Mignotte, et al.. (2001). Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. European Journal of Cancer. 37(18). 2365–2372. 49 indexed citations
20.
Giard, S., et al.. (1996). PP-2-8 Axillary lymphadenectomy prepared by fat aspiration versus functional axillary lymphadenectomy (fal): Preliminary results of a prospective randomized trial. Bulletin du Cancer. 84(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stella Hetelekidis Breakdown of academic impact, for papers by J.P. Travagli Breakdown of academic impact, for papers by Pandora Ashley Breakdown of academic impact, for papers by Kristine E. Kokeny Breakdown of academic impact, for papers by Ashu Gandhi Breakdown of academic impact, for papers by Shu Wan Kau Breakdown of academic impact, for papers by Hanne Melgaard Nielsen Breakdown of academic impact, for papers by Werner Audretsch Breakdown of academic impact, for papers by F. Laki Breakdown of academic impact, for papers by Jai Min Ryu
Rankless by CCL
2026